SciThera

SciThera is a biotech company in San Diego, United States. It has raised $26.0M across 1 round, most recently a $26.0M Seed in 2025 (est.).

Business Model
B2B
Total Funding
$26.0M
Last Round
$26.0M SeedJan 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

SciThera, Inc. is a San Diego, California-based biotechnology company focused on discovering and developing novel antibody-based therapeutics, including antibody-drug conjugates, for the treatment of cancer. According to an SEC filing by Inhibrx, SciThera is a newly formed biotechnology company that focuses on antibody-based molecules and has entered into a licensing agreement with Inhibrx. SciThera is backed by venture capital firm Venrock and led by CEO Brendan Eckelman.

Summary

It has raised $26.0M in total across 1 round, most recently a $26.0M Seed round in 2025 (est.). Investors include Venrock.

Funding History

Data from Indexed.vcUpdated
SeedSeed Round2025 (est.)
$26.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SciThera on Indexed.vc
<a href="https://indexed.vc/companies/scithera"><img src="https://indexed.vc/api/badge/company/scithera" alt="SciThera on Indexed.vc" width="260" height="76" /></a>